ASN 2021 - Physician's Weekly


Advertisement

ASN 2021

Imaging Gout in the Spine

Patients with gout have significantly greater intercritical inflammation and lumbosacral spine monosodium urate crystal (MSU) deposition when compared with those without the condition, and trend toward greater deposition among...

PROTECTing Renal Transplant Recipients From Uncontrolled Gout

In the phase IV open-label PROTECT trial of pegloticase therapy (pegylated recombinant uricase) in treating severe gout in renal transplant recipients, 89% of patients achieved the primary endpoint of serum uric acid (sUA) less...

Gout in Dialysis-Dependent Patients: An Unrecognized Problem

In a dialysis-dependent population, patients with gout showed a higher cardiovascular comorbidity burden and an increased risk of hospitalization and mortality, compared with patients without gout. In addition, older age,...

ASN Kidney Week Learning Pathways

The following learning pathways will help attendees locate sessions in their area of interest: Acute Kidney Injury Bone and Mineral Metabolism Cell and Transport Physiology Chronic Kidney Disease Development and Pediatrics...

ASN Kidney Week 2021 Program, FAQs & Meeting Overview

With increasing uncertainties around variants of the COVID-19 virus, ASN has canceled plans for the in-person component of ASN Kidney Week 2021 in San Diego, CA, and chosen a fully virtual experience for attendees. Access the...

Among Patients With CKD, Gout Is Common & Impactful

With evidence that gout highly impacts patients with advanced CKD, through increased healthcare utilization and higher cardiovascular and bone/joint comorbidity and patients with uncontrolled gout (UCG) show to have an even...

Loading

Advertisement

For latest news and updates
Email-id is invalid